Showing results (21-30 of 57) with videos related to
Sort By:
Pageof 6
International Journal of Clinical Oncology|September 29, 2017
MMC/UFT/LV in refractory colorectal cancer: phase II study and analysis of predictive variables of progressionChiara Baratelli, Marco Tampellini, Massimo Di Maio, et al.Endocrine Pathology|May 18, 2022
External Validation of Three Available Grading Systems for Medullary Thyroid Carcinoma in a Single Institution CohortElena Vissio, Francesca Maletta, Jessica Fissore, et al.La Radiologia Medica|September 8, 2016
Changes in hepatic perfusion assessed by dynamic contrast enhanced MRI, associated with morphologic evaluation, in patients with liver metastases from colorectal cancer treated with first-line chemotherapyMarco Tampellini, Dario Gned, Chiara Baratelli, et al.Anticancer Research|November 27, 2008
Gemcitabine and protracted 5-fluorouracil infusion as third-line chemotherapy in refractory colorectal cancer patientsRaffaella Bitossi, Carla Maria Sculli, Marco Tampellini, et al.Anticancer Research|November 1, 2016
Bioequivalence of Branded and Generic Oxaliplatin: From Preclinical Assessment to Clinical Incidence of Hypersensitivity ReactionsMarco Tampellini, Simone Benedetto, Elena Rubatto, et al.Neuroendocrinology|January 31, 2015
Expression analysis of genes involved in DNA repair or synthesis in mixed neuroendocrine/nonneuroendocrine carcinomasMarco Volante, Valentina Monica, Nadia Birocco, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 11, 2011
Metastatic and locally advanced pancreatic endocrine carcinomas: analysis of factors associated with disease progressionFrancesco Panzuto, Letizia Boninsegna, Nicola Fazio, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 13, 2002
Changes in microvessel density as assessed by CD34 antibodies after primary chemotherapy in human breast cancerAlberto Bottini, Alfredo Berruti, Alessandra Bersiga, et al.Breast Cancer Research and Treatment|August 4, 2010
Anti-angiogenic effect of tamoxifen combined with epirubicin in breast cancer patientsTeresa Mele, Daniele Generali, Stephen Fox, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 18, 2007
Somatostatin receptor type 2A immunohistochemistry in neuroendocrine tumors: a proposal of scoring system correlated with somatostatin receptor scintigraphyMarco Volante, Maria Pia Brizzi, Antongiulio Faggiano, et al.Pageof 6